Counterfeit controlled prescription drug availability in Pennsylvania and Delaware.
(eBook)
Published
[Washington, D.C.] : Drug Enforcement Administration, Strategic Intelligence Section, 2020.
Status
Description
Loading Description...
Also in this Series
Checking series information...
More Details
Format
eBook
Language
English
Notes
General Note
"September 2020."
General Note
Unclassified.
General Note
GPO Cataloging Record Distribution Program (CRDP).
Citations
APA Citation, 7th Edition (style guide)
(2020). Counterfeit controlled prescription drug availability in Pennsylvania and Delaware . Drug Enforcement Administration, Strategic Intelligence Section.
Chicago / Turabian - Author Date Citation, 17th Edition (style guide)2020. Counterfeit Controlled Prescription Drug Availability in Pennsylvania and Delaware. Drug Enforcement Administration, Strategic Intelligence Section.
Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 17th Edition (style guide)Counterfeit Controlled Prescription Drug Availability in Pennsylvania and Delaware Drug Enforcement Administration, Strategic Intelligence Section, 2020.
MLA Citation, 9th Edition (style guide)Counterfeit Controlled Prescription Drug Availability in Pennsylvania and Delaware Drug Enforcement Administration, Strategic Intelligence Section, 2020.
Note! Citations contain only title, author, edition, publisher, and year published. Citations should be used as a guideline and should be double checked for accuracy. Citation formats are based on standards as of August 2021.
Staff View
Grouped Work ID
1e0653f1-a479-2461-5bb0-591a2af4cbfd-eng
Grouping Information
| Grouped Work ID | 1e0653f1-a479-2461-5bb0-591a2af4cbfd-eng |
|---|---|
| Full title | counterfeit controlled prescription drug availability in pennsylvania and delaware |
| Author | drug enforcement administration strategic intellig |
| Grouping Category | book |
| Last Update | 2022-07-13 05:41:45AM |
| Last Indexed | 2024-07-13 23:03:17PM |
Book Cover Information
| Image Source | default |
|---|---|
| First Loaded | Feb 13, 2024 |
| Last Used | Jun 24, 2024 |
Marc Record
| First Detected | Dec 14, 2020 12:00:00 AM |
|---|---|
| Last File Modification Time | Aug 18, 2021 09:41:05 AM |
MARC Record
| LEADER | 01509nam a2200409 i 4500 | ||
|---|---|---|---|
| 001 | on1226746120 | ||
| 003 | OCoLC | ||
| 005 | 20201214153915.0 | ||
| 006 | m o d f | ||
| 007 | cr ||||||||||| | ||
| 008 | 201214s2020 dcuab o f000 0 eng c | ||
| 040 | |a GPO|b eng|e rda|e pn|c GPO|d MvI | ||
| 042 | |a pcc | ||
| 043 | |a n-us--- | ||
| 074 | |a 0967-L-03 (online) | ||
| 086 | 0 | |a J 24.34:035-20 | |
| 099 | |a J 24.34:035-20 | ||
| 245 | 0 | 0 | |a Counterfeit controlled prescription drug availability in Pennsylvania and Delaware. |
| 264 | 1 | |a [Washington, D.C.] :|b Drug Enforcement Administration, Strategic Intelligence Section,|c 2020. | |
| 300 | |a 1 online resource (8 pages) :|b color illustrations, color maps. | ||
| 336 | |a text|b txt|2 rdacontent | ||
| 337 | |a computer|b c|2 rdamedia | ||
| 338 | |a online resource|b cr|2 rdacarrier | ||
| 490 | 1 | |a DEA intelligence report ;|v DEA-PHL-DIR-035-20 | |
| 500 | |a "September 2020." | ||
| 500 | |a Unclassified. | ||
| 500 | |a GPO Cataloging Record Distribution Program (CRDP). | ||
| 588 | |a Description based on online resource, PDF version; title from cover (DEA website, viewed Dec. 14, 2020). | ||
| 650 | 0 | |a Drug adulteration. | |
| 650 | 0 | |a Product counterfeiting|z Pennsylvania. | |
| 650 | 0 | |a Product counterfeiting|z Delaware. | |
| 650 | 0 | |a Fentanyl|z Pennsylvania. | |
| 650 | 0 | |a Fentanyl|z Delaware. | |
| 830 | 0 | |a DEA intelligence report ;|v 035-20. | |
| 856 | 4 | 0 | |u https://purl.fdlp.gov/GPO/gpo148820 |
| 922 | |a BIBCONEW|b 20201214 | ||
| 949 | |a J 24.34:035-20|t x | ||
